(Q33773132)

29 July 2017

1 reference

title

Review of 10 years of the clinical use of brain natriuretic peptide in cardiology (English)

1 reference

brain natriuretic peptide

29 July 2017

0 references

author name string

Valli N

series ordinal

1

1 reference

29 July 2017

Gobinet A

series ordinal

2

1 reference

29 July 2017

Bordenave L

series ordinal

3

1 reference

29 July 2017

1 November 1999

1 reference

29 July 2017

Translational Research

1 reference

29 July 2017

134

1 reference

29 July 2017

5

1 reference

29 July 2017

437-444

1 reference

A new natriuretic peptide in porcine brain.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Brain natriuretic peptide in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Atrial Natriuretic Peptide and Brain Natriuretic Peptide Coexist in the Secretory Granules of Human Cardiac Myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Natriuretic peptide system in human heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Augmented secretion of brain natriuretic peptide in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Relaxant effect of human brain natriuretic peptide on human artery and vein tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Brain natriuretic peptide in an elderly population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Increased human brain natriuretic peptide in congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Biochemical detection of left-ventricular systolic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma brain natriuretic peptide in assessment of acute dyspnoea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma concentration of brain natriuretic peptide is related to diastolic function in hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Human brain natriuretic peptide, a novel cardiac hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Brain natriuretic peptide as a cardiac hormone in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Exercise-Induced Secretion of Brain Natriuretic Peptide in Essential Hypertension and Normal Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Changes in the E/A ratio induced by handgrip-exercise are related to changes in the plasma atrial natriuretic peptide level, but not to changes in brain natriuretic peptide in mild essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients with left ventricular hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Increased plasma levels of B-type natriuretic peptide in patients with unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Increased plasma concentrations of brain natriuretic peptide in patients with acute lung injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma concentrations of atrial, brain, and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Acute neurohormonal responses to hypoxaemia in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Cardiovascular Function during Brain Natriuretic Peptide Infusion in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Natriuretic peptides in the treatment of heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Suppression of hyperventilation-induced attacks with infusion of B-type (brain) natriuretic peptide in patients with variant angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

Influence of candoxatril on plasma brain natriuretic peptide in heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990163-4

10.1016/S0022-2143(99)90163-4

7 January 2021

Identifiers

DOI

1 reference

release_jbnzxl544vakjix6v7bs3syyny

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jbnzxl544vakjix6v7bs3syyny

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference